Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 6, keine Gesamtzahl für „rituximab“
Suchtreffer
Begriffe & Kennungen
Ituxredi · 4.8 · The safety profile of rituximab in paediatric GPA or MPA patients was consistent in type, nature and severity
Eintrag öffnenItuxredi · 4.8 · The safety profile of rituximab in paediatric patients (aged 6 months to less than 18 years old) with previous
Eintrag öffnenItuxredi · 4.8 · The safety profile of rituximab in patients with moderate to severe rheumatoid arthritis (RA) is summarised in
Eintrag öffnenLenalidomide Accord · 4.8 · 43 patients in the placebo/rituximab arm; neither patient had a Grade 3 or 4 event. TLS occurred in 1 FL patie
Eintrag öffnenLenalidomide Accord · 4.8 · Follicular lymphoma The overall safety profile of lenalidomide in combination with rituximab in patients with
Eintrag öffnenLenalidomide Accord · 4.8 · In study NHL-007, TFR was reported in 19/146 (13.0 %) of patients in the lenalidomide/rituximab arm versus 1/1
Eintrag öffnenLenalidomide Accord · 4.8 · In the NHL-007 study the adverse reactions observed more frequently in the lenalidomide/rituximab arm compared
Eintrag öffnenLenalidomide Accord · 4.8 · Lenalidomide in combination with rituximab is also associated with a higher incidence of grade 3 or 4 thromboc
Eintrag öffnenLenalidomide Accord · 4.8 · • Follicular lymphoma patients The combination of lenalidomide with rituximab in follicular lymphoma is associ
Eintrag öffnenLenalidomide Krka (previously Lenalidomide Krka d.d. Novo mesto) · 4.8 · Follicular lymphoma The overall safety profile of lenalidomide in combination with rituximab in patients with
Eintrag öffnenLenalidomide Krka (previously Lenalidomide Krka d.d. Novo mesto) · 4.8 · Follicular lymphoma patients The combination of lenalidomide with rituximab in follicular lymphoma is associat
Eintrag öffnenLenalidomide Krka (previously Lenalidomide Krka d.d. Novo mesto) · 4.8 · In study NHL-007, TFR was reported in 19/146 (13.0%) of patients in the lenalidomide/rituximab arm versus 1/14
Eintrag öffnenLenalidomide Krka (previously Lenalidomide Krka d.d. Novo mesto) · 4.8 · In the NHL-007 study the adverse reactions observed more frequently in the lenalidomide/rituximab arm compared
Eintrag öffnenLenalidomide Krka (previously Lenalidomide Krka d.d. Novo mesto) · 4.8 · Lenalidomide in combination with rituximab is also associated with a higher incidence of Grade 3 or 4 thromboc
Eintrag öffnenLenalidomide Krka d.d. Novo mesto (previously Lenalidomide Krka) · 4.8 · 32 or 4 thrombocytopenia (1.4% in lenalidomide/rituximab treated patients compared to 0% in placebo/rituximab
Eintrag öffnenLenalidomide Krka d.d. Novo mesto (previously Lenalidomide Krka) · 4.8 · 33 arm versus 1/148 (0.7%) patients in the placebo/rituximab arm. Most TFRs (18 out of 19) reported in the len
Eintrag öffnenLenalidomide Krka d.d. Novo mesto (previously Lenalidomide Krka) · 4.8 · Follicular lymphoma The overall safety profile of lenalidomide in combination with rituximab in patients with
Eintrag öffnenLenalidomide Krka d.d. Novo mesto (previously Lenalidomide Krka) · 4.8 · Follicular lymphoma patients The combination of lenalidomide with rituximab in follicular lymphoma is associat
Eintrag öffnenLenalidomide Krka d.d. Novo mesto (previously Lenalidomide Krka) · 4.8 · In the NHL-007 study the adverse reactions observed more frequently in the lenalidomide/rituximab arm compared
Eintrag öffnenLenalidomide Krka d.d. Novo mesto (previously Lenalidomide Krka) · 4.8 · Lenalidomide in combination with rituximab is also associated with a higher incidence of Grade 3
Eintrag öffnen